Gene Zlotnikov, Senior Director, Consumer Marketing, Rare Disease, Amgen

Mark Silverman, Director, Enterprise Digital Advancement & Innovation, AbbVie 

Gaetan Akinrolobu, Senior Director, Corporate Content & Omni-Channel Strategy, BMS 

Facilitated by Brett Kleger, CEO, Inspire

Pharma’s omnichannel efforts have too often been piecemeal, producing short-term wins but limited long-term impact. To truly reach omnichannel maturity, commercial leaders must prove ROI, avoid fragmented investments, and make the case for sustained infrastructure that drives measurable business value. This panel explores how to move from campaigns to scalable platforms that deliver real returns.

• Building financial models that connect omnichannel investments directly to revenue growth and efficiency gains
• Investing in infrastructure and shifting funding from one-off initiatives toward scalable platforms that deliver long-term value
• Breaking down silos to prioritize investments that support both patient engagement and sustainable business outcomes
• Analyzing fragmented omni investments to identify what to stop doing and how to reinvest smarter 

Gene Zlotnikov, Senior Director, Consumer Marketing, Rare Disease, Amgen

Mark Silverman, Director, Enterprise Digital Advancement & Innovation, AbbVie 

Gaetan Akinrolobu, Senior Director, Corporate Content & Omni-Channel Strategy, BMS 

Facilitated by Brett Kleger, CEO, Inspire

Pharma’s omnichannel efforts have too often been piecemeal, producing short-term wins but limited long-term impact. To truly reach omnichannel maturity, commercial leaders must prove ROI, avoid fragmented investments, and make the case for sustained infrastructure that drives measurable business value. This panel explores how to move from campaigns to scalable platforms that deliver real returns.

• Building financial models that connect omnichannel investments directly to revenue growth and efficiency gains
• Investing in infrastructure and shifting funding from one-off initiatives toward scalable platforms that deliver long-term value
• Breaking down silos to prioritize investments that support both patient engagement and sustainable business outcomes
• Analyzing fragmented omni investments to identify what to stop doing and how to reinvest smarter 

Participate in a 50-minute interactive discussion with a leading pharma executive to explore best practices and actionable strategies to reach your target audience. Walk away with insider tips to engage your buyers more strategically. 

Table 1: Facilitated by Stuart Davis, Global Director of Marketing, CSL Behring

Table 2: Facilitated by Tarak Shah, Senior Director, Digital Strategy & Activation Lead, Bayer